Related references
Note: Only part of the references are listed.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
D. Erlinge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
Shuo Zhang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies
Tilak Pasala et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial
Sergio Leonardi et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial
Sergio Leonardi et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials
Davide Capodanno et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2016)
Individual participant data meta-analyses compared with meta-analyses based on aggregate data
Catrin Tudur Smith et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials
Monica Verdoi et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2016)
Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction The BRIGHT Randomized Clinical Trial
Yaling Han et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes
M. Valgimigli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction
Stefanie Schulz et al.
EUROPEAN HEART JOURNAL (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
Matthew A. Cavender et al.
LANCET (2014)
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
Adeel Shahzad et al.
LANCET (2014)
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients at High Risk for Bleeding
Alexander Feldman et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2014)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
CIRCULATION (2013)
Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention
Adnan K. Chhatriwalla et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Bivalirudin Started during Emergency Transport for Primary PCI
Philippe Gabriel Steg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study)
Giuseppe Patti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Abciximab and Heparin versus Bivalirudin for Non-ST-Elevation Myocardial Infarction
Adnan Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions -: Appropriateness of including bleeding as a component of a quadruple end point
Gjin Ndrepepa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Bivalirudin during primary PCI in acute myocardial infarction
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
Gregg W. Stone et al.
LANCET (2007)
Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data
Jan O. Friedrich et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Share Paper
